All In MedTech

FDA Clearance Tracker · P200035

OrganOx metra System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Dec 9, 2021 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Dec 9, 2021

Approved

Time to decision

512 days

Received Jul 15, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P200035
Device name
OrganOx metra System
Applicant location
Oxford
Received
Jul 15, 2020
Decided
Dec 9, 2021
Decision
Approved
Supplements
40 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code QQK

FDA's approval statement

As written in FDA's record.

Approval for the OrganOx metra System. The device is approved for the following indication: The OrganOx metra® is a transportable device intended to be used to sustain donor livers destined for transplantation in a functioning state for a total preservation time of up to 12 hours.The OrganOx metra® device is suitable for liver grafts from donors after brain death (DBD), or liver grafts from donors after circulatory death (DCD) <=40 years old, with <=20 mins of functional warm ischemic time (time from donor systolic blood pressure <50 mmHg), and macrosteatosis <=15%, in a near-physiologic, normothermic and functioning state intended for a potential transplant recipient.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code QQK. The earliest in FDA's data is P200031, decided Sep 28, 2021.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Organox Limited

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.